Exploration of schizophrenia-associated gene modules using graph theory, co-expression networks, and dimensionality reduction.
Overview
Abstract
The PsychENCODE consortium has generated a comprehensive multi-omic dataset from human brain samples, spanning healthy individuals and those with neuropsychiatric disorders. In this study, we focus exclusively on schizophrenia and analyze PsychENCODE transcriptomic data to construct gene regulatory and co-expression networks, aiming to uncover biologically and clinically relevant gene modules. We apply three independent analytical approaches to the same dataset. First, we preprocess the data using Surrogate Variable Analysis (SVA) to correct for latent variation and normalize gene expression. For graph-based analysis, we use Pearson correlation and the igraph package to construct gene co-expression networks and apply Prim’s algorithm to generate minimum spanning trees (MST) and compute centrality measures. Next, we implement Weighted Gene Co-expression Network Analysis (WGCNA), assuming a scale-free topology, to identify modules associated with schizophrenia traits. Dimensionality reduction is performed using Principal Component Analysis (PCA), with visualization aided by t-distributed Stochastic Neighbor Embedding (t-SNE) and Multidimensional Scaling (MDS). Functional enrichment is carried out using Gene Ontology (GO) and KEGG pathway databases. Each method reveals distinct yet complementary biological signatures associated with schizophrenia. The igraph-based approach highlights differentially expressed genes (DEGs) with high centrality, uncovering hub genes involved in mRNA export, synaptic signaling, and ion transport. WGCNA identifies co-expression modules strongly correlated with schizophrenia diagnosis, enriched for immune response, histone modification, and mRNA surveillance pathways. PCA isolates key genes contributing to diagnostic variance, with enrichment in neurotransmitter release cycles and cytokine signaling. Collectively, these results underscore the involvement of immune, synaptic, and epigenetic processes in schizophrenia and demonstrate the power of using multiple, orthogonal analytical lenses.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
No file of the authors' code could be read here: it is described below, and read at its source.
supp:PMC13082716/pone.0346663.s008.zip
Availability: 1 check, the latest on 29 September 2026: the link answers (HTTP 200)
- 29 September 2026: the link answers (HTTP 200)
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 0 scripts, each with its path and the digest of its content;
- no match between paragraphs and code yet;
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
Datasets cited
- doi:10.7303/
syn4921369 , at the source; found in “Data Availability”
Data Availability
All relevant data for this study are publicly available from the Synapse repository (https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 29 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 2 authors, 9 MeSH terms, 42 references.
Cite
This paper
Bampos, C., & Megalooikonomou, V. (2026). Exploration of schizophrenia-associated
BibTeX
@article{bampos2026explo
author = {Bampos, Costas and Megalooikonomou, Vasileios},
title = {{Exploration of schizophrenia-associated
journal = {PloS one},
year = {2026},
month = apr,
volume = {21},
number = {4},
pages = {e0346663},
publisher = {PLOS},
issn = {1932-6203},
doi = {10.1371/
url = {https://
pmid = {41984900},
pmcid = {PMC13082716}
}
RIS
TY - JOUR
AU - Bampos, Costas
AU - Megalooikonomou, Vasileios
TI - Exploration of schizophrenia-associated
T2 - PloS one
J2 - PLoS One
PY - 2026
DA - 2026/
VL - 21
IS - 4
SP - e0346663
SN - 1932-6203
PB - PLOS
DO - 10.1371/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1371/
"type": "article-journal",
"title": "Exploration of schizophrenia-associated
"container-title": "PloS one",
"author": [
{
"family": "Bampos",
"given": "Costas"
},
{
"family": "Megalooikonomou",
"given": "Vasileios"
}
],
"container-title-short":
"volume": "21",
"issue": "4",
"page": "e0346663",
"DOI": "10.1371/
"PMID": "41984900",
"PMCID": "PMC13082716",
"ISSN": "1932-6203",
"publisher": "PLOS",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
15
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41588-026-02646-3 [code]
- Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated
genes. Journal: Nature geneticsIn common: schizophrenia / psychosis, genetics / omics, cellular / molecular, 8 references - [2] doi:10.1038/s41467-026-71542-5 [code]
- Astrocyte fatty acid metabolism as a driver of risk for major depressive disorder.Journal: Nature communicationsIn common: genetics / omics, cellular / molecular, 6 references
- [3] doi:10.1038/s41467-026-75470-2 [code]
- Analysis of gene co-expression connectivity dynamics implicates aberrant neuron-oligodendroglia interactions in schizophrenia.Journal: Nature communicationsIn common: schizophrenia / psychosis, genetics / omics, 5 references
- [4] doi:10.1038/s41467-026-71281-7 [code]
- Downregulated transcription in chromosomal domains of midbrain dopamine neurons linked to schizophrenia.Journal: Nature communicationsIn common: schizophrenia / psychosis, cellular / molecular, 4 references
- [5] doi:10.1038/s41386-026-02406-1 [code]
- Functional genomic profiling of schizophrenia-associated
genes reveals key microglial regulators. Journal: Neuropsychopharmacology : official publication of the American College of NeuropsychopharmacologyIn common: schizophrenia / psychosis, genetics / omics, cellular / molecular, 4 references - [6] doi:10.1038/s41380-026-03574-8
- Genome-wide tandem repeat expansions modify schizophrenia risk in the presence of a 22q11.2 deletion.Journal: Molecular psychiatryIn common: schizophrenia / psychosis, genetics / omics, 3 references
- [7] doi:10.1038/s41380-026-03571-x [code]
- Convergent coexpression reveals shared biological mechanisms underlying common and rare variant risk in six neuropsychiatric disorders.Journal: Molecular psychiatryIn common: genetics / omics, cellular / molecular, 4 references
- [8] doi:10.3390/ijms27136083
- Systematic Evaluation of Competing Brain Transcriptomic Representations Reveals Reciprocal Patterns Across Heterogeneous Contexts.Journal: International journal of molecular sciencesIn common: genetics / omics, cellular / molecular, 3 references
- [9] doi:10.1371/journal.pcbi.1014323 [code]
- A prototype-augmented graph representation learning framework for identifying brain disorder-associated genes and facilitating drug repurposing.Journal: PLoS computational biologyIn common: genetics / omics, cellular / molecular, 3 references
- [10] doi:10.1126/sciadv.aea0755
- Schizophrenia risk gene ZNF804A controls ribosome localization and synaptogenesis in developing human neurons.Journal: Science advancesIn common: schizophrenia / psychosis, genetics / omics, cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 1 repository of the authors' code, each at its verified commit and with its license, 0 scripts, and 0 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:2650997548554894…
Add the badge to its README
The badge links the code to this page. Copy one of these into the README of the paper's code: only you decide where it goes, and nothing is changed for you.
Markdown
[.
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
